107 related articles for article (PubMed ID: 3928960)
21. Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
Pollera CF; Calabresi F
Oncology; 1989; 46(4):238-44. PubMed ID: 2740067
[TBL] [Abstract][Full Text] [Related]
22. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of high-dose metoclopramide in cancer patients.
McGovern EM; Grevel J; Bryson SM
Clin Pharmacokinet; 1986; 11(6):415-24. PubMed ID: 3542335
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.
Bateman DN; Kahn C; Mashiter K; Davies DS
Br J Clin Pharmacol; 1978 Nov; 6(5):401-7. PubMed ID: 728283
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
Stephens SH; Silvey VL; Wheeler RH
Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
[TBL] [Abstract][Full Text] [Related]
27. High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
Ostrow S; Egorin MJ; Hahn D; Markus S; Aisner J; Chang P; LeRoy A; Bachur NR; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):73-8. PubMed ID: 6784924
[TBL] [Abstract][Full Text] [Related]
28. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J
Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911
[TBL] [Abstract][Full Text] [Related]
29. A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis.
Akhtar SS; Bano ZA; Bhat GM; Bhat MA
Oncology; 1991; 48(3):226-9. PubMed ID: 2023702
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics of metoclopramide in man with observations in the dog.
Bateman DN; Kahn C; Davies DS
Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
[TBL] [Abstract][Full Text] [Related]
31. A single dose of metoclopramide in the control of vomiting from cis-dichlorodiammineplatinum(II) in man.
Kahn T; Elias EG; Mason GR
Cancer Treat Rep; 1978 Jul; 62(7):1106-7. PubMed ID: 688250
[No Abstract] [Full Text] [Related]
32. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
[TBL] [Abstract][Full Text] [Related]
33. [Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine].
Aasebø U; Myhr K
Tidsskr Nor Laegeforen; 1985 Jan; 105(2):148-9. PubMed ID: 4038825
[No Abstract] [Full Text] [Related]
34. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting].
Hatae M; Nakamura Y; Mitsuo M; Sakurai K; Asano H; Onishi Y; Hokanishi H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1495-9. PubMed ID: 2389945
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.
Allan SG; Cornbleet MA; Warrington PS; Golland IM; Leonard RC; Smyth JN
Br Med J (Clin Res Ed); 1984 Oct; 289(6449):878-9. PubMed ID: 6434122
[No Abstract] [Full Text] [Related]
37. Combination antiemetic therapy in cisplatin-induced nausea and vomiting.
Krebs HB; Myers MB; Wheelock JB; Goplerud DR
Cancer; 1985 Jun; 55(11):2645-8. PubMed ID: 3888367
[TBL] [Abstract][Full Text] [Related]
38. Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
Ell C; König HJ; Brockmann P; Domschke S; Domschke W
Oncology; 1985; 42(6):354-7. PubMed ID: 4069550
[TBL] [Abstract][Full Text] [Related]
39. High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma.
Onsrud M; Moxnes A; Sollien A; Grande T; Solesvik O
Cancer; 1988 Jun; 61(12):2429-32. PubMed ID: 3365665
[TBL] [Abstract][Full Text] [Related]
40. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
Fujii M; Kiura K; Tamai M; Okabe K; Toki H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]